Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

Launched by R3 STEM CELL · Dec 29, 2017

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a special treatment called Amniotic Fluid Tissue Product for helping people with various musculoskeletal conditions, such as osteoarthritis, tendinitis, sports injuries, and more. The goal is to see if this treatment can relieve pain and improve how well participants can move and function in their daily lives. The trial is not yet recruiting participants, but when it starts, it will follow patients over time to track their progress after receiving the treatment.

To be eligible for this trial, participants need to be at least 18 years old and able to communicate about their experience, either in person or through phone or email. It's important that they can understand the study and agree to take part voluntarily. However, individuals with active infections, those who are pregnant or breastfeeding, and those with certain blood clotting disorders will not be able to join the study. If you or someone you know is interested, this trial could offer a new option for managing musculoskeletal pain and improving quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18 and over.
• • 2. Ability to attend follow up visits or at least converse on phone or complete email follow up forms.
• • 4) Competent to understand the study protocol and provide voluntary informed consent.
• Exclusion Criteria:
• • 1. Active Infection
• • 2. Pregnancy, Lactating
• • 3. Clotting disorder